Back to search

Article

Ribosomal biogenesis factor, a novel biomarker for predicting progression-free survival in prostate cancer

2024-10-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Prostate cancer (PCa) is the second most common malignancy among men worldwide, with significant variability in incidence rates across different regions. Effective management of PCa is crucial, especially for advanced stages where the survival rates are notably low. Ribosome biogenesis (RB) plays a critical role in cancer cell proliferation, yet the specific func...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b1095912-830c-519f-8dee-4dcfe6b832a1
DOI
10.21203/rs.3.rs-4899995/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ribosomal biogenesis factor, a novel biomarker for predicting progression-free survival in prostate cancerDOI 10.21203/rs.3.rs-4899995/v1
Construction and Verification of a Prognostic Model for Prostate Cancer based on Ribosome Biogenesis-Related GenesSemantic proximity
Constructing lactylation-related genes prognostic model to effectively predict the disease-free survival and treatment responsiveness in prostate cancer based on machine learningSemantic proximity
Prognostic Model Identification of Ribosome Biogenesis-Related Genes in Pancreatic Cancer Based on Multiple Machine Learning AnalysesSemantic proximity
Prostate cancer biomarker analysis and drug target prediction based on bioinformatics analysisSemantic proximity
Unveiling prognostic genes and regulatory mechanisms of exosome in prostate cancer: an integrated analysis of bulk transcriptomics and single-cell RNA sequencing dataSemantic proximity
Integrated analysis of single‑cell and bulk RNA‑sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsivenessSemantic proximity
Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer.Semantic proximity
Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factorsSemantic proximity
Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancerSemantic proximity
An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancerSemantic proximity
Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancerSemantic proximity
MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancerSemantic proximity
Select a neighboring publication to make it the new centre.